mk 0852 has been researched along with arginyl-glycyl-aspartyl-serine in 1 studies
| Studies (mk 0852) | Trials (mk 0852) | Recent Studies (post-2010) (mk 0852) | Studies (arginyl-glycyl-aspartyl-serine) | Trials (arginyl-glycyl-aspartyl-serine) | Recent Studies (post-2010) (arginyl-glycyl-aspartyl-serine) |
|---|---|---|---|---|---|
| 17 | 2 | 0 | 503 | 0 | 79 |
| Protein | Taxonomy | mk 0852 (IC50) | arginyl-glycyl-aspartyl-serine (IC50) |
|---|---|---|---|
| Integrin beta-3 | Homo sapiens (human) | 4.17 | |
| Integrin beta-1 | Homo sapiens (human) | 2.2 | |
| Integrin alpha-IIb | Homo sapiens (human) | 4.17 | |
| Integrin alpha-5 | Homo sapiens (human) | 2.2 | |
| Integrin beta | Oryctolagus cuniculus (rabbit) | 5.1 | |
| Glycoprotein IIb | Oryctolagus cuniculus (rabbit) | 5.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lages, B; Weiss, HJ | 1 |
1 other study(ies) available for mk 0852 and arginyl-glycyl-aspartyl-serine
| Article | Year |
|---|---|
Greater inhibition of platelet procoagulant activity by antibody-derived glycoprotein IIb--IIIa inhibitors than by peptide and peptidomimetic inhibitors.
Topics: Abciximab; Antibodies, Monoclonal; Blood Platelets; Calcium; Cytosol; Enzyme Inhibitors; Eptifibatide; Fura-2; Humans; Immunoglobulin Fab Fragments; Immunoglobulin Fragments; Oligopeptides; Peptides; Peptides, Cyclic; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thiazolidines; Thromboplastin | 2001 |